BioNTech SE (XTER:22UA)
€ 104.5 5.1 (5.13%) Market Cap: 24.57 Bil Enterprise Value: 8.11 Bil PE Ratio: 0 PB Ratio: 1.25 GF Score: 67/100

Q4 2023 BioNTech SE Earnings Call Transcript

Mar 20, 2024 / 12:00PM GMT
Release Date Price: €81.52 (-5.91%)
Operator

Welcome to the BioNTech's Fourth Quarter and Full Year 2023 Earnings Call.

I would like to hand the call over to Dr. Victoria Meissner, Vice President of Strategy and Investor Relations. Please go ahead.

Victoria Meissner

Thank you. Good morning and good afternoon. Thank you for joining BioNTech's fourth quarter and full year 2023 earnings Call. As a reminder, the slides we'll be using during this call and the corresponding press release we issued this morning can be found in the Investor Relations section of our website.

On the next slide, you will see our forward-looking statements disclaimer. Additional information about these statements and other risks are described in our filings with the U.S. Securities and Exchange Commission. Forward-looking statements in this call are subject to significant risks and uncertainties, speak only as of the date of this conference call, and we undertake no obligation to update or revise any of these statements. On Slide 3, you can find the agenda for today's call.

Today, I'm joined by the following

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot